Inactive ingredients in medicines. 1988

V Rippere

UI MeSH Term Description Entries
D004348 Drug Labeling Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information. Labeling, Drug,Package Inserts, Drug,Product Labeling, Drug,Black Box Warning,Boxed Warning,Drug Labelling,Black Box Warnings,Box Warning, Black,Box Warnings, Black,Boxed Warnings,Drug Package Insert,Drug Package Inserts,Drug Product Labeling,Insert, Drug Package,Inserts, Drug Package,Labeling, Drug Product,Labelling, Drug,Package Insert, Drug,Warning, Black Box,Warning, Boxed,Warnings, Black Box,Warnings, Boxed
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Rippere
May 1988, Lancet (London, England),
V Rippere
August 1988, Lancet (London, England),
V Rippere
December 1985, FDA drug bulletin,
V Rippere
March 2019, Science translational medicine,
V Rippere
January 1987, Pediatric nursing,
V Rippere
June 1988, Lancet (London, England),
V Rippere
January 2007, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique,
V Rippere
September 2022, Briefings in bioinformatics,
V Rippere
August 2015, Current opinion in insect science,
V Rippere
December 2009, Ear, nose, & throat journal,
Copied contents to your clipboard!